Information  X 
Enter a valid email address

Angel Biotechnology (ABH)

  Print      Mail a friend

Friday 12 June, 2009

Angel Biotechnology

Angel and Biosource Sign GMP

RNS Number : 8263T
Angel Biotechnology Holdings Plc
12 June 2009


12th June 2009


('Angel' or 'the Company')


Angel Biotechnology plc and BioOutsource Sign GMP Testing Contract

Angel Biotechnology Holdings plc, (AIM: ABH) the biopharmaceutical contract manufacturer, is pleased to announce the signing of an agreement with BioOutsource Ltd, a leading Bio-testing company. Under the agreement, BioOutsource will provide GMP bio-safety testing of commercial bio-pharmaceutical products being manufactured by Angel Biotechnology for its clients.  

The agreement with BioOutsource complements Angel's strategy for sustained growth, while offering best value solutions for its clients. A cornerstone of this strategy is to partner with high quality, specialist organizations that can support Angel's unique advanced biologics manufacturing offering.

Gordon Sherriff, COO of Angel Biotechnology plc said 'We are very happy to be working with BioOutsource. We are impressed with the level of expertise that they bring to the project. We look forward to further collaborations with BioOutsource in the future, supporting our growing pipeline of advanced biologics' manufacturing projects for clinical trial and commercial applications.'

Commenting on the contract, Robert Reid, Managing Director said 'We are delighted to enter in to this contract with Angel Biotechnology. Angel is one of the UK's leading CMOs and I'm very happy that they have chosen BioOutsource to support their process development and manufacturing activities. We look forward to working with Angel in future projects'.

For further information, please call:

Angel Biotechnology Holdings plc

Tel: +44 (0) 131 445 6077

Gordon Sherriff - COO

Tel: +44 (0) 7951 057016

Grant Thornton UK LLP

Philip Secrett, Colin Aaronson

Tel+44 (0) 20 7383 5100 

About Angel Biotechnology Holdings plc

Angel Biotechnology Holdings plc is a biomanufacturing company offering process development services and GMP manufacturing for advanced biologics, supporting biotechnology and pharmaceutical companies worldwide.  Angel's principal activity is the manufacture and supply of materials for use in early stage drug development and pre-clinical studies, along with drug product and CMC documentation for Phases I, II and III clinical trials and the manufacture of licensed drugs or vaccines.  Angel specializes in the provision of advanced biologics including  autologous and allogeneic cell therapy products including stem cells and cellular vaccines, specific purified natural and recombinant proteins and bacteriophage.  Angel is managed by a team with wide ranging experience in biopharmaceutical manufacture, gained in companies such as Glaxo, Johnson and Johnson, Serologicals Inc., PPL Therapeutics and Intercell Ag.

Angel was admitted to trading on AIM in November 2005. More information about the Company can be found at


BioOutsource is a leading provider of GMP-compliant lot release testing services to Biotech, Pharmaceutical and Vaccine companies worldwide. Our first-class scientific team operates within a purpose-built, GMP-certified facility in GlasgowScotland

BioOutsource offers:

  • State-of-the-art technologies and an up-to-date understanding of regulatory requirements

  • Scientific leadership through a highly experienced technical team

  • GMP quality- approved by the MHRA

  • Openness and transparency of operation through the world-leading BioWeb technology

For more information on BioOutsource, please see

This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t